Osteoporosis: Starting Anti-Osteoporosis Therapy — free guideline decision tool
This tool decides whether to start anti-osteoporosis therapy and at what intensity, integrating fragility-fracture history, BMD T-score, and FRAX 10-year fracture probability.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Common questions
What does Osteoporosis: Starting Anti-Osteoporosis Therapy do?
Use to triage treatment: a hip/vertebral fragility fracture or T-score ≤ -2.5 mandates therapy, while low bone mass is treated when accompanied by another fragility fracture or high FRAX risk.
How is the result calculated?
Treat if hip/vertebral fragility fracture, T ≤ -2.5, or low bone mass (-2.5 < T ≤ -1.0) with another fragility fracture or FRAX major ≥ 20%/hip ≥ 3%. Very high risk (FRAX major > 30%/hip > 4.5%, T ≤ -3.0) selects more potent agents.
Is this a substitute for clinical judgement?
No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.
Run Osteoporosis: Starting Anti-Osteoporosis Therapy now
This tool decides whether to start anti-osteoporosis therapy and at what intensity, integrating fragility-fracture history, BMD T-score, and FRAX 10-year fracture probability.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.